Hot Topics and Issues in the Biosimilars Space: Part Two
February 1, 2018

Axinn joined the New York Intellectual Property Law Association Patent Litigation and Women in IP Law committees in hosting "Hot Topics and Issues in the Biosimilars Space: Part Two." As a follow-up to the NYIPLA's 2016 program, panelists — including Axinn partner Chad Landmon — discussed recent case law and updates in FDA implementation and policy development. Strategies for clearing intellectual property hurdles involving biologics in inter partes reviews and the mechanics of the patent dance were also addressed.

This event took place on February 1, 2018 at Axinn's New York office.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.